Immunity to Infections after Haploidentical Hematopoietic Stem Cell Transplantation
暂无分享,去创建一个
[1] F. Locatelli,et al. Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] W. Hiddemann,et al. Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[3] U. Şahin,et al. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[4] L. Moretta,et al. Specific removal of alloreactive T-cells to prevent GvHD in hemopoietic stem cell transplantation: rationale, strategies and perspectives. , 2016, Blood reviews.
[5] A. Bacigalupo,et al. HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide , 2016, Advances in hematology.
[6] L. Luznik,et al. Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide. , 2016, Seminars in hematology.
[7] M. V. D. van den Brink,et al. Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[8] M. Ramanathan,et al. Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies , 2016, Advances in hematology.
[9] Yu Wang,et al. Differential impact of two doses of antithymocyte globulin conditioning on lymphocyte recovery upon haploidentical hematopoietic stem cell transplantation , 2015, Journal of Translational Medicine.
[10] A. Vekhoff,et al. Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients , 2015, Transplant infectious disease : an official journal of the Transplantation Society.
[11] Weilin Wang,et al. Gut microbiota and allogeneic transplantation , 2015, Journal of Translational Medicine.
[12] R. Vij,et al. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. , 2015, Blood.
[13] Christopher G. Kanakry,et al. Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia. , 2015, Seminars in hematology.
[14] R. Krance,et al. Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation. , 2015, Blood.
[15] Yu Wang,et al. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. , 2015, Blood.
[16] G. Ledderose,et al. Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings , 2015, Annals of Hematology.
[17] P. Bartolomeo,et al. Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update , 2015, Bone Marrow Transplantation.
[18] M. Ebinger,et al. Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients , 2015, Bone Marrow Transplantation.
[19] He Huang,et al. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[20] A. Moretta,et al. γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes. , 2015, Blood.
[21] C. Carlo-Stella,et al. Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis , 2015, Transplant infectious disease : an official journal of the Transplantation Society.
[22] M. Ebinger,et al. Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients , 2014 .
[23] A. Ferretti,et al. Epidemiology and risk factors for invasive fungal diseases in hematopoietic stem cell transplantation , 2014, Current opinion in hematology.
[24] M. Gobbi,et al. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[25] H. Einsele,et al. Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] C. Cancrini,et al. HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. , 2014, Blood.
[27] B. Falini,et al. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. , 2014, Blood.
[28] Loren Gragert,et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. , 2014, The New England journal of medicine.
[29] P. Chiusolo,et al. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[30] Daniel Wolff,et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[31] L. Brandt,et al. Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease. , 2014, Gastroenterology & hepatology.
[32] L. Giordano,et al. Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin’s lymphoma , 2014, Bone Marrow Transplantation.
[33] F. Aversa,et al. Haploidentical Stem Cell Transplantation After Negative Depletion Of T Cells Expressing The αβ Chain Of The T-Cell Receptor (TCR) For Adults With Hematological Malignancies , 2013 .
[34] S. Kako,et al. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] A. Nagler,et al. Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies. , 2013, Blood.
[36] Xiao-jun Huang,et al. Haploidentical bone marrow transplantation without T-cell depletion. , 2012, Seminars in oncology.
[37] M. Konopleva,et al. Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[38] D. Roy,et al. Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation. , 2012, Seminars in oncology.
[39] M. Martelli,et al. Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity. , 2012, Seminars in oncology.
[40] R. Handgretinger. New approaches to graft engineering for haploidentical bone marrow transplantation. , 2012, Seminars in oncology.
[41] N. Socci,et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] A. Tosti,et al. Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT , 2012, Bone Marrow Transplantation.
[43] David A. Relman,et al. Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota , 2012, Cell.
[44] R. Khanin,et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation , 2012, The Journal of experimental medicine.
[45] H. Tamaki,et al. Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation , 2012, Annals of Hematology.
[46] R. Champlin,et al. Progress in haploidentical stem cell transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[47] M. Martelli,et al. Haploidentical hematopoietic transplantation: current status and future perspectives. , 2011, Blood.
[48] Adrian P Gee,et al. Inducible apoptosis as a safety switch for adoptive cell therapy. , 2011, The New England journal of medicine.
[49] Vu H Nguyen,et al. Role of gut microbiota in graft-versus-host disease , 2011, Leukemia & lymphoma.
[50] B. Falini,et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. , 2011, Blood.
[51] I. Benet,et al. Surveillance for adenovirus DNAemia early after transplantation in adult recipients of unrelated-donor allogeneic stem cell transplants in the absence of clinically suspected infection , 2011, Bone Marrow Transplantation.
[52] M. Ciofani,et al. Determining γδ versus αβ T cell development , 2010, Nature Reviews Immunology.
[53] D. Kasper,et al. Microbiota-stimulated immune mechanisms to maintain gut homeostasis. , 2010, Current opinion in immunology.
[54] M. Aepfelbacher,et al. Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny , 2010, Leukemia & lymphoma.
[55] E. Thiel,et al. Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion , 2010, International journal of hematology.
[56] Thomas J Walsh,et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[57] A. Ganser,et al. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. , 2009, The Lancet. Oncology.
[58] M. Martelli,et al. Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications , 2009, Clinical and experimental immunology.
[59] Yu-Hong Chen,et al. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[60] F. Derouin,et al. Prevention of toxoplasmosis in transplant patients. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[61] F. Aversa,et al. Unmanipulated or CD34 selected haplotype mismatched transplants , 2008, Current opinion in hematology.
[62] Allen R. Chen,et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[63] M. Robin,et al. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome , 2007, Haematologica.
[64] Mark Ende,et al. Hematopoietic stem-cell transplantation. , 2006, The New England journal of medicine.
[65] Wei Han,et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies , 2006, Bone Marrow Transplantation.
[66] A. Tosti,et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. , 2005, Blood.
[67] C. Mecucci,et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] C. Bordignon,et al. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation. , 2005, Cytotherapy.
[69] H. Einsele,et al. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. , 2003, Blood.
[70] D. Maloney,et al. Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantation. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[71] S. Lonial,et al. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[72] A. Hagenbeek,et al. Safety of retroviral gene marking with a truncated NGF receptor , 2003, Nature Medicine.
[73] S. Riddell,et al. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. , 2003, Blood.
[74] D. Porter,et al. Post-transplant lymphoproliferative disorder: a review , 2003, Bone Marrow Transplantation.
[75] N. Chao,et al. Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. , 2002, Blood.
[76] R. Collins,et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. , 2001, Blood.
[77] V. Kuenen-Boumeester,et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. , 2000, Blood.
[78] M Pittard,et al. Adenovirus infections in hematopoietic stem cell transplant recipients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[79] A. Casrouge,et al. A Direct Estimate of the Human αβ T Cell Receptor Diversity , 1999 .
[80] M. Martelli,et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. , 1998, The New England journal of medicine.
[81] S. Bauer,et al. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. , 1998, Science.
[82] F. Aversa,et al. Use of stem cells from mismatched related donors , 1997, Current opinion in hematology.
[83] M. Umesue,et al. [Cyclophosphamide-induced immunological tolerance: an overview]. , 1996, Nihon Geka Gakkai zasshi.
[84] C. Mackall,et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. , 1996, Journal of immunology.
[85] F. Aversa,et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. , 1994, Blood.
[86] S. Kaufmann,et al. Primary responses of human T cells to mycobacteria: a frequent set of γ/δ T cells are stimulated by protease‐resistant ligands , 1990 .
[87] P. Thomas,et al. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[88] A. Gratwohl,et al. The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT , 2014, Bone Marrow Transplantation.
[89] T. Lamparelli,et al. Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[90] P. Ljungman,et al. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. , 2006, Haematologica.
[91] M. Boccadoro,et al. Corticosteroids can reverse severe imatinib-induced hepatotoxicity. , 2006, Haematologica.
[92] H. Einsele,et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[93] A. Casrouge,et al. A direct estimate of the human alphabeta T cell receptor diversity. , 1999, Science.
[94] S. Kaufmann,et al. Primary responses of human T cells to mycobacteria: a frequent set of gamma/delta T cells are stimulated by protease-resistant ligands. , 1990, European journal of immunology.
[95] M. Mikulska,et al. Mediterranean Journal of Hematology and Infectious Diseases Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients , 2022 .
[96] R. de la Cámara. Mediterranean Journal of Hematology and Infectious Diseases Cmv in Hematopoietic Stem Cell Transplantation , 2022 .